Evaluation of Patients With Liver Disease
Recruiting now
Conditions studied: Hepatitis D, Hepatitis C, Hepatitis B, Liver Disease
In brief
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up. Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations. Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
Key facts
- Study ID
- NCT00001971
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 8050
- Starts
- 1992-05-27
- Last updated by the study team
- 2026-08-07
Who can join
Age: 2 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Affected Participants
- An affected participant who meets any of the following criteria will be excluded from participation in this study:
- History of significant medical illnesses that might interfere with prolonged follow up evaluation
- Healthy Volunteers
- A healthy volunteer who meets any of the following criteria will be excluded from participation in this study:
- Any chronic medical condition, including (but not limited to) heart, kidney, or lung diseases
- Taking any regular medications or supplements (with the exception of regular multivitamins and/or oral contraceptives)
- Average alcohol consumption > 1 drink/day in past 6 months, per self-report
- History of liver disease (with the exception of neonatal jaundice)
- History of severe illness, infection or major surgery in the past year
- History of cancer (with the exception of basal cell carcinoma resected > 1 year prior to enrollment)
- BMI < 18 or BMI >25
- Hemoglobin < 11 (women) or hemoglobin < 12 (men)
- ALT >35 (men) or ALT >25 (women)
- Alkaline Phosphatase >= 150
- Bilirubin >2 g/dL
- HIV positive, Anti-HCV positive, HBsAg positive or Anti-HBc positive
- Pregnancy
- Inability to provide informed consent
Where it is running
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.